What is NeoGenomics's investment proceeds?

NeoGenomics (NEO) reported investment proceeds of $0 in Q1 2026.

How has NeoGenomics's investment proceeds changed year-over-year?

NeoGenomics's investment proceeds decreased by 100.0% year-over-year, from $8.06M to $0.

What is the long-term trend for NeoGenomics's investment proceeds?

Over 4 years (2021 to 2025), NeoGenomics's investment proceeds has grown at a -24.9% compound annual growth rate (CAGR), from $62.97M to $20.06M.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

NeoGenomics NEO Investment Proceeds

Investment Proceeds at other companies

Personalis, Inc.PSNL

$24.1M-45.5%

Natera, Inc.NTRA

$0-100%

Tempus AI, Inc.TEM

$0-100%

GeneDx HoldingsWGS

$875K—

Opko HealthOPK

$0-100%

ImmunomeIMNM

$0-100%

Other financials

Income statement

See full

Revenue$186.7M+11.1%

Gross profit$80.9M+10.4%

Operating income-$18.2M+34.4%

Net income-$17.1M+34.0%

EPS (diluted)-$0.13+35.0%

Balance sheet

See full

Cash & equivalents$146.1M-57.8%

Total debt$66.3M+5.3%

Total equity$828.8M-6.7%

Total assets$1.3B-15.9%

Cash flow

See full

Operating cash flow-$8.1M+67.9%

CapEx$5.0M+11.1%

Free cash flow-$13.1M+56.0%

Valuation

See full

Market cap$1.68B+86.5%

Enterprise value$1.6B+159%

P/S2.3×+0.9×

Profitability

See full

Gross margin43.2%-1.1pp

Operating margin-14.2%+1.1pp

Net margin-13.3%+2.4pp

FCF margin-4.9%—

Returns & leverage

See full

Return on equity-11.6%+6.2pp

Debt / equity0.1×0.0×

Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NeoGenomics's investment proceeds?: NeoGenomics (NEO) reported investment proceeds of $0 in Q1 2026.
How has NeoGenomics's investment proceeds changed year-over-year?: NeoGenomics's investment proceeds decreased by 100.0% year-over-year, from $8.06M to $0.
What is the long-term trend for NeoGenomics's investment proceeds?: Over 4 years (2021 to 2025), NeoGenomics's investment proceeds has grown at a -24.9% compound annual growth rate (CAGR), from $62.97M to $20.06M.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.